BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 16570180)

  • 1. Expression patterns of dysadherin and E-cadherin in lymph node metastases of colorectal carcinoma.
    Batistatou A; Charalabopoulos AK; Scopa CD; Nakanishi Y; Kappas A; Hirohashi S; Agnantis NJ; Charalabopoulos K
    Virchows Arch; 2006 Jun; 448(6):763-7. PubMed ID: 16570180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma: immunohistochemical analysis of 115 patients.
    Nishizawa A; Nakanishi Y; Yoshimura K; Sasajima Y; Yamazaki N; Yamamoto A; Hanada K; Kanai Y; Hirohashi S
    Cancer; 2005 Apr; 103(8):1693-700. PubMed ID: 15751018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysadherin overexpression in pancreatic ductal adenocarcinoma reflects tumor aggressiveness: relationship to e-cadherin expression.
    Shimamura T; Sakamoto M; Ino Y; Sato Y; Shimada K; Kosuge T; Sekihara H; Hirohashi S
    J Clin Oncol; 2003 Feb; 21(4):659-67. PubMed ID: 12586803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In breast carcinoma dysadherin expression is correlated with invasiveness but not with E-cadherin.
    Batistatou A; Peschos D; Tsanou H; Charalabopoulos A; Nakanishi Y; Hirohashi S; Agnantis NJ; Charalabopoulos K
    Br J Cancer; 2007 May; 96(9):1404-8. PubMed ID: 17437014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of dysadherin and E-cadherin expression in differentiated-type gastric carcinoma with submucosal invasion.
    Maehata Y; Hirahashi M; Aishima S; Kishimoto J; Hirohashi S; Yao T; Takashima H; Tsuneyoshi M; Oda Y
    Hum Pathol; 2011 Apr; 42(4):558-67. PubMed ID: 21239043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the dysadherin and E-cadherin expression in primary lung cancer and metastatic sites.
    Mitselou A; Batistatou A; Nakanishi Y; Hirohashi S; Vougiouklakis T; Charalabopoulos K
    Histol Histopathol; 2010 Oct; 25(10):1257-67. PubMed ID: 20712010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of dysadherin expression in advanced colorectal carcinoma.
    Aoki S; Shimamura T; Shibata T; Nakanishi Y; Moriya Y; Sato Y; Kitajima M; Sakamoto M; Hirohashi S
    Br J Cancer; 2003 Mar; 88(5):726-32. PubMed ID: 12618882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
    Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M
    Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of dysadherin expression in tongue cancer: immunohistochemical analysis of 91 cases.
    Nakanishi Y; Akimoto S; Sato Y; Kanai Y; Sakamoto M; Hirohashi S
    Appl Immunohistochem Mol Morphol; 2004 Dec; 12(4):323-8. PubMed ID: 15536331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of dysadherin expression in patients with non-small cell lung cancer.
    Tamura M; Ohta Y; Tsunezuka Y; Matsumoto I; Kawakami K; Oda M; Watanabe G
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):740-5. PubMed ID: 16153922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of E-cadherin independently predicts the lymph node status in colorectal cancer.
    Karamitopoulou E; Zlobec I; Patsouris E; Peros G; Lugli A
    Pathology; 2011 Feb; 43(2):133-7. PubMed ID: 21233674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysadherin expression in head and neck squamous cell carcinoma: association with lymphangiogenesis and prognostic significance.
    Kyzas PA; Stefanou D; Batistatou A; Agnantis NJ; Nakanishi Y; Hirohashi S; Charalabopoulos K
    Am J Surg Pathol; 2006 Feb; 30(2):185-93. PubMed ID: 16434892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival.
    Liu J; Ikeguchi M; Nakamura S; Kaibara N
    J Exp Clin Cancer Res; 2002 Mar; 21(1):65-71. PubMed ID: 12071532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of proliferating cell nuclear antigen and CD44 variant exon 6 in primary tumors and corresponding lymph node metastases of colorectal carcinoma with Dukes' stage C or D.
    Zhang JC; Wang ZR; Cheng YJ; Yang DZ; Shi JS; Liang AL; Liu NN; Wang XM
    World J Gastroenterol; 2003 Jul; 9(7):1482-6. PubMed ID: 12854146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Snail promotes lymph node metastasis and Twist enhances tumor deposit formation through epithelial-mesenchymal transition in colorectal cancer.
    Fan XJ; Wan XB; Yang ZL; Fu XH; Huang Y; Chen DK; Song SX; Liu Q; Xiao HY; Wang L; Wang JP
    Hum Pathol; 2013 Feb; 44(2):173-80. PubMed ID: 22974478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The level of expression of adhesion molecules CD44v6 and E-cadherin in colorectal cancer and analysis of correlates with metastasis].
    Gu J; Zhu X; Ye Y; Qu J; Huang L; Li R; Yu Y; Leng X
    Zhonghua Wai Ke Za Zhi; 1999 Feb; 37(2):108-9, 4. PubMed ID: 11829796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of dysadherin and cytokeratin as prognostic indicators of disease-free survival in patients with stage I NSCLC.
    Ono K; Uramoto H; Hanagiri T
    Anticancer Res; 2010 Sep; 30(9):3273-8. PubMed ID: 20944097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E-cadherin and DAP kinase in pancreatic adenocarcinoma and corresponding lymph node metastases.
    Dansranjavin T; Möbius C; Tannapfel A; Bartels M; Wittekind C; Hauss J; Witzigmann H
    Oncol Rep; 2006 May; 15(5):1125-31. PubMed ID: 16596173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E-cadherin expression in primary colorectal cancer and metastatic lymph nodes.
    Palaghia M; Mihai C; Lozneanu L; Ciobanu D; Trofin AM; Rotariu A; Târcoveanu F; Cijevschi Prelipcean C
    Rom J Morphol Embryol; 2016; 57(1):205-9. PubMed ID: 27151709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of dysadherin and E-cadherin expression in patients with head and neck cancer treated by radiation therapy.
    Muramatsu H; Akimoto T; Maebayashi K; Kita M; Mitsuhashi N
    Anticancer Res; 2008; 28(6B):3859-64. PubMed ID: 19192641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.